Dana-Farber announces $30 million gift from Albert A. Marcotte, PhD


Albert MarcotteAlbert A. Marcotte, PhD

A $30 million gift from Albert A. Marcotte, PhD, will support Dana-Farber Cancer Institute’s Capital Projects Campaign to expand research and clinical space, the Institute announced today. This transformational gift will also create the Marcotte Center for Cancer Research at Dana-Farber and advance strategic cancer research initiatives underway at the Institute.

Marcotte’s significant investment in the Institute’s Capital Projects Campaign will help Dana-Farber carry out a number of key expansion projects already underway, including: revitalizing the Charles A. Dana Building; expanding the Jimmy Fund Clinic; building out the Molecular Cancer Imaging Facility; and customizing lab space in the Longwood Center. With these enhancements, Dana-Farber can continue to attract the most talented and world-renowned physician-scientists, and remain at the forefront of translational cancer research, accelerating discovery, and delivery of compassionate patient care.

The Marcotte Center for Cancer Research will be located directly across the street from the Yawkey Center for Cancer Care, Dana-Farber’s patient care center. The twin centers’ positioning tangibly reflects the Institute’s unique and balanced commitment to research and patient care–a commitment that enables an extraordinary level of collaboration between Dana-Farber scientists and clinicians, and speeds the translation of laboratory discoveries into lifesaving treatments for patients.

In making this gift, Dr. Marcotte noted, “We are entering a new era where advances in cancer research will move treatments from coping to cures. By recognizing unique differences in various cancers, future research will develop new paradigms that lead to earlier detection, targeted treatments and increased survival rates. With its broad spectrum of strategic research initiatives, Dana-Farber is uniquely positioned to make significant advances in cancer research and patient care.”

“Our goal is to bring the latest basic and clinical research advances from the lab to the clinic as soon as possible,” said Edward J. Benz Jr., MD, president and CEO of Dana-Farber Cancer Institute. “Dr. Marcotte’s transformational gift will help speed that process and help bring the benefits of cancer research to more people sooner. We are grateful for his support and for his dedication to our shared mission of advancing cancer research and patient care.”

Dr. Marcotte earned his Ph.D. from the Sloan School of Management at the Massachusetts Institute of Technology where he taught for more than two decades in the Senior Executive Program. At MIT, he pioneered the development and use of simulation-based education for upper level managers. His research laid the foundation for improving management decision making by utilizing computer-based systems to support executive decision making processes.

In 1979, Dr. Marcotte founded and is still President of Advanced Management Systems, (AMS), a firm dedicated to improving the performance of service organizations. In the late ’70s, little was known about managing service organizations. Recognizing the need for a new quantitative methodology, he developed the underlying theory, concepts, tools and techniques for improving the effectiveness and efficiency of service operation. More than 40,000 managers have attended AMS’s Management Developmental Programs. Today, AMS methodology is used by leading banks, insurance companies and brokerage firms throughout the world.

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • Media Contacts

    • For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to media@dfci.harvard.edu.